Prevalence of complications among Chinese diabetic patients in urban primary care clinics: A cross-sectional study

BMC Family Practice

Volumn 15, Issue 1, 2014, Pages

  Kung, Kenny ^a   Chow, Kai Ming ^b   Hui, Eric Ming Tung ^a   Leung, Maria ^a   Leung, Shuk Yun ^a   Szeto, Cheuk Chun ^b   Lam, Augustine ^a   Li, Philip Kam Tao ^a,b  

^a HOSPITAL AUTHORITY   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chronic illness; Diabetic complications; Primary care; Screening program

Indexed keywords

ADULT; AGED; ARTICLE; ASIAN; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; HEALTH; HONG KONG; HUMAN; MALE; MIDDLE AGED; PREVALENCE; PRIMARY HEALTH CARE; RISK ASSESSMENT; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; FEMALE; HONG KONG; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PRIMARY HEALTH CARE; RISK ASSESSMENT; URBAN HEALTH; YOUNG ADULT;

EID: 84892428473     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-15-8     Document Type: Article

References (20)

1. World Health Organisation, Diabetes Programme 2012 http://www.who.int/ diabetes/en/
2. International Diabetes Federation, The Global Burden. In Diabetes Atlas 2012 http://www.idf.org/sites/default/files/The-Global-Burden.pdf
3. Global estimates of the prevalence of diabetes for 2010 and 2030. Shaw JE, Sicree RA, Zimmet PZ, Diabetes Res Clin Pract 2010 87 4 14 10.1016/j.diabres.2009.10.007 19896746
4. The reference framework for diabetes care in primary care settings. Wong MC, Sin CK, Lee JP, Hong Kong Med J 2012 18 238 246 22665689
5. Centers for Disease Control and Prevention, National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011 Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention 2011
6. The Information Centre, NHS, National Diabetes Audit Executive Summary 2009-2010. National Diabetes Audit 2011 http://www.hqip.org.uk/assets/NCAPOP- Library/National-Diabetes-Audit-Executive-Summary-2009-2010.pdf
7. Factors associated with antihypertensive drug discontinuation among Chinese patients: a cohort study. Wong MC, Jiang JY, Gibbs T, Griffiths SM, A J Hypertens 2009 22 802 810 10.1038/ajh.2009.67
8. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Wing RR, Arch Intern Med 2010 170 1566 1575 20876408
9. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Gaede P, Vedel P, Parving HH, Pedersen O, Lancet 1999 353 617 622 10.1016/S0140-6736(98)07368- 1 10030326 (Pubitemid 29087981)
10. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. UK Prospective Diabetes Study Group, BMJ 1998 317 703 713 10.1136/bmj.317.7160. 703 9732337
11. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HAW, Livingstone SJ, et al. Lancet 2004 364 685 696 10.1016/S0140-6736(04)16895-5 15325833 (Pubitemid 39140624)
12. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Collins R, Armitage J, Parish S, Sleigh P, Peto R, Lancet 2003 361 2005 2016 12814710
13. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Heart Protection Study Collaborative Group, Lancet 2002 360 7 22 12114036
14. Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors. Sacks FM, Tonkin AM, Craven T, Pfeffer MA, Shepherd J, Keech A, et al. Circulation 2002 105 1424 1428 10.1161/01.CIR.0000012918.84068.43 11914249 (Pubitemid 34263272)
15. The prevalence of peripheral neuropathy in a population-based study of patients with type 2 diabetes in Sweden. Karvestedt L, Martensson E, Grill V, Elofsson S, Von Wendt G, Hamsten A, Brismar K, J Diabetes Complications 2011 25 97 106 10.1016/j.jdiacomp.2010.04.001 20488731
16. Prevalence and risk factors for diabetic microvascular complications in newly diagnosed type II diabetes mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 27). Raman R, Gupta A, Krishna S, Kulothungan V, Sharma T, J Diabetes Complications 2012 26 123 128 10.1016/j.jdiacomp.2012.02.001 22446033
17. Prevalence of chronic complications of type 2 diabetes mellitus in outpatients-a cross-sectional hospital based survey in urban China. Liu Z, Fu C, Wang W, Xu B, Health Qual Life Outcomes 2010 8 62 10.1186/1477-7525-8-62 20579389
18. Comprehensive risk assessments of diabetic patients from seven Asian countries: The Joint Asia Diabetes Evaluation (JADE) program. So WY, Raboca J, Sobrepena L, Yoon KH, Deerochanawong C, Ho LT, Himathongkam T, Tong P, Lyubomirsky G, Ko G, Nan H, Chan J, JADE Program Research Team, J Diabetes 2011 3 109 118 10.1111/j.1753-0407.2011.00115.x 21599865
19. Deterimination of peripheral neuropathy prevalence and associated factors in Chinese subjects with diabetes and pre-diabetes-ShangHai Diabetic neuRopathy Epidemiology and Molecular Genetics Study (SH-DREAMS). Lu B, Hu J, Wen J, Zhang Z, Zhou L, Li Y, Hu R, PLoS One 2013 8 61053 10.1371/journal.pone.0061053 23613782
20. The crisis in diabetes care in England. Rayman G, Kilvert A, BMJ 2012 345 5446 10.1136/bmj.e5446 22896031